Foghorn Therapeutics Inc.
FHTX
Revenue
5.95M
▲3.10M▲108.40%
3 Months ChangeAssets
258.69M
▼-25.29M▼-8.91%
3 Months ChangeLiabilities
320.34M
▼-9.17M▼-2.78%
3 Months ChangeFree Cash Flow
-24.00M
▲5.45M▲18.51%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-10
Form 8-K
ID: 0001628280-24-042630
2024-08-08
Form 10-Q
ID: 0001628280-24-035867
2024-08-08
Form 8-K
ID: 0001628280-24-035864
2024-06-26
Form 8-K
ID: 0001628280-24-030137
2024-06-03
Form 8-K
ID: 0001628280-24-026294
2024-05-23
Form 8-K
ID: 0001628280-24-024811
2024-05-22
Form 8-K
ID: 0001193125-24-144934
2024-05-20
Form 8-K
ID: 0001628280-24-024217
2024-05-06
Form 8-K
ID: 0001628280-24-020698
2024-05-06
Form 10-Q
ID: 0001628280-24-020455